Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial GuidanceBusiness Wire • 1 day ago
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its second quarter ended...
Share to Feed
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial...
This is a Bullish indicator signaling SRDX's price could rise from here. Traders may explore going long the stock or buying call options...
This is a signal that SRDX's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that management will participate in the following...
This is a Bullish indicator signaling SRDX's price could rise from here. Traders may explore going long the stock or buying call options...
This is a Bullish indicator signaling SRDX's price could rise from here. Traders may explore going long the stock or buying call options...
This is a signal that SRDX's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Surmodics ( NASDAQ:SRDX ) First Quarter 2024 Results Key Financial Results Revenue: US$30.6m (up 23% from 1Q 2023). Net...